Company: QTIWW
Filing Date: 2025-02-05
Form Type: 424B3
Source: 0001628280-25-004061
Chunk: 162

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-02-05
Form: 424B3
Chunk 162
---
 Other income (expense), net                  |     |                        |     16,995 |     |      |          — |     |        |     16,995 |     |      |  100 | %    |
| Change in fair value of warrant liability    |     |                        |      8,805 |     |      |          — |     |        |      8,805 |     |      |  100 | %    |
| Change in fair value of derivative liability |     |                        |     87,200 |     |      |          — |     |        |     87,200 |     |      |  100 | %    |
| Change in fair value of earnout liability    |     |                        |     50,000 |     |      |          — |     |        |     50,000 |     |      |  100 | %    |
| Interest expense, net                        |     |                        | -1,455,306 |     |      |   -132,844 |     |        | -1,322,462 |     |      | -995 | %    |
| Net loss and comprehensive loss              |     |                      $ | -3,619,494 |     |    $ | -1,375,939 |     | $      | -2,243,555 |     |      | -163 | %    |

N.M. - Not meaningful

#### Revenue
Revenue increased by $931,313 to $955,970 for the three months ended September 30, 2024 from $24,657 for the three months ended September 30, 2023. The increase in revenue was primarily attributable to the sale of two QT Breast Scanners in the third quarter of 2024 as compared with no scanners sold in the third quarter of 2023 due to the timing of sales orders received, availability of scanners that were earmarked and ready for sale to customers.

#### Cost of Revenue
Cost of revenue increased by $326,868 to $350,667 for the three months ended September 30, 2024 from $23,799 for the three months ended September 30, 2023. The increase in cost of revenue was primarily attributable to the sale of two QT Breast Scanners in the third quarter of 2024 as compared with no scanners sold in the third quarter of 2023.

#### Operating Expenses
Research and Development Expenses

Research and development expenses increased by $